Seroepidemiology of hepatitis B virus infection among children in Mongolia: Results of a nationwide survey

Pediatrics International

Volumn 49, Issue 3, 2007, Pages 368-374

  Davaalkham, Dambadarjaa ^a,b   Ojima, Toshiyuki ^a   Nymadawa, Pagvajav ^c   Tsend, Navaansodov ^c   Lkhagvasuren, Tserenkhuu ^b   Wiersma, Steven ^d   Uehara, Ritei ^a   Watanabe, Makoto ^a   Oki, Izumi ^a   Nakamura, Yosikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Health Sciences University   (Mongolia)

^c National Center for Communicable Diseases   (Mongolia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Children; Hepatitis B virus; Mongolia; Seroepidemiologic study; Universal immunization

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LIVER ENZYME;

AGE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; HEALTH SURVEY; HEPATITIS B; HUMAN; LIVER FUNCTION TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONGOLIA; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEX DIFFERENCE; URBAN AREA;

CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; INCIDENCE; MALE; MONGOLIA; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION;

EID: 33847647203     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02364.x     Document Type: Article

References (34)

1. Alter MJ. Epidemiology and prevention of hepatitis B. Semin. Liver Dis. 2003 23 : 39 46.
2. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: A global overview. Vaccine 2000 19 : 1026 37.
3. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 1996 38 : S18 23.
4. Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 2002 347 : 168 74.
5. The EASL Jury. EASL international consensus conference on hepatitis B (Special article). J. Hepatol. 2003 38 : 533 40.
6. National Center for Health Development, Ministry of Health of Mongolia. Government of Mongolia, Annual Health Report-2004. Ministry of Health of Mongolia, Government of Mongolia, Ulaanbaatar, 2004.
7. Fujioka S, Shimomura H, Ishii Y et al. Prevalence of hepatitis B and C virus markers in outpatients of Mongolian general hospitals. Kansenshogaku Zasshi 1998 72 : 5 11.
8. Nymadawa P. Research findings on medical virology in the last ten years and the future directions. Mong. Med. Sci. 1995 2 : 3 8.
9. Oyunsuren T. Viral hepatitis in Mongolia. Minophagen Med. Rev. 2000 45 : 140 47.
10. Takahashi M, Nishizawa T, Gotanda Y et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C and D viruses among apparently healthy populations in Mongolia. Clin. Diagn. Lab. Immunol. 2004 11 : 392 8.
11. Nymadawa P. Hepatitis B vaccination: Worldwide and in Mongolia (Abstract). In : The 10th National Conference on Current Topics of Virology, Ulaanbaatar, Mongolia, 2004. National Communicable Disease Center, Ulaanbaatar, 2004 115 16.
12. Alimaa D, Nymadawa N. Pathogenic agents and epidemiologic features of acute and chronic hepatitis, primary liver cancer. Mong. Med. Sci. 1995 2 : 23 8.
13. Kondo Y, Mizokami M, Nakano T et al. Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia. J. Med. Virol. 1997 52 : 143 8.
14. Chang MH, Shau WY, Chen CJ et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000 284 : 3040 42.
15. Ni YH, Chang MH, Huang LM et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann. Intern. Med. 2001 135 : 796 800.
16. Harpaz R, McMahon BJ, Margolis HS et al. Elimination of new chronic hepatitis B virus infections: Results of the Alaska immunization program. J. Infect. Dis. 2000 181 : 413 18.
17. Poovorawan Y, Theamboonlers A, Vimolket T et al. Impact of hepatitis B immunization as part of the EPI. Vaccine 2000 19 : 943 9.
18. Whittle HC, Maine N, Pilkington J et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 1995 345 : 1089 92.
19. Mele A, Stroffolini T, Zanetti AR. Hepatitis B in Italy: Where we are ten years after the introduction of mass vaccination. J. Med. Virol. 2002 67 : 440 43.
20. Goldstein ST, Alter MJ, Williams IT et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: Implications for vaccination programs. J. Infect. Dis. 2002 185 : 713 19.
21. Shepard CW, Finelli L, Fiore AE, Bell BP. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr. Infect. Dis. J. 2005 24 : 755 60.
22. Davaasuren D. Epidemiology and some clinical peculiarities of viral hepatitis B, C and D among children of Ulaanbaatar City, Mongolia. PhD thesis, Health Sciences University, Ulaanbaatar, 2001.
23. Ministry of Education, Technology, Sciences, and Culture of Mongolia. A Statistical Report-2003. Ministry of Education, Technology, Sciences, and Culture, Ulaanbaatar, 2003.
24. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev. Med. 2002 34 : 207 14.
25. Dagwadorj Ya, Bayarmagnai B, Sarangoo G, Baigal B, Tsogtsaikhan S. Some issues on epidemiology of HBV and HDV infections in Mongolia (Abstract). In : The 10th National Conference on Current Topics of Virology, Ulaanbaatar, 2004. National Communicable Disease Center, Ulaanbaatar, 2004 131.
26. Edstam JS, Nyamkhuu D, Orgil Ts, Baasandorj D, Batochir D. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev. Med. 2004 39 : 384 8.
27. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann. Intern. Med. 2001 135 : 759 68.
28. Soderstrom A, Norkrans G, Conradi N, Krantz M, Horal P, Lindh M. Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors. J. Pediatr. Gastroenterol. Nutr. 2002 35 : 487 94.
29. Margolis HS. Prevention of acute and chronic liver disease through immunization: Hepatitis B and beyond. J. Infect. Dis. 1993 168 : 9 14.
30. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 2000 342 : 1266 71.
31. Cahen DL, van Leeuwen DJ, ten Kate FJ, Blok AP, Oosting J, Chamuleau RA. Do serum ALT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis? Liver 1996 16 : 105 9.
32. Yuen MF, Ng IO, Fan ST et al. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B. Am. J. Gastroenterol. 2004 99 : 2032 7.
33. Lee A, Cheng FF, Chan CS, Lau LC, Lo AS. Sero-epidemiology and risk factors of positive hepatitis B surface antigen among Chinese adolescents. Asia Pac. J. Public Health 2001 13 : 30 35.
34. Bovet P, Yersin C, Herminie P et al. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bull. World Health Organ. 1999 77 : 923 8.